Debabrata Saha

Department of Radiation Oncology, University of Texas Southwestern Medical Center

Affiliated withUniversity of Texas Southwestern Medical Center

Research Area

Biography

Debabrata Saha has not added Biography.
If you are Debabrata Saha and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 16	2011

Other Publications

Article	Year
New strategies for colorectal cancer prevention and treatment. World journal of surgery\| PubMed ID: 11948369	2002
Resistance to transforming growth factor-beta occurs in the presence of normal Smad activation. Surgery\| PubMed ID: 12219028	2002
Potential for combined modality therapy of cyclooxygenase inhibitors and radiation. Progress in experimental tumor research\| PubMed ID: 12795056	2003
COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer. American journal of clinical oncology\| PubMed ID: 12902860	2003
Potential radiation-sensitizing effect of semisynthetic epothilone B in human lung cancer cells. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology\| PubMed ID: 13129641	2003
The antiangiogenic agent SU5416 down-regulates phorbol ester-mediated induction of cyclooxygenase 2 expression by inhibiting nicotinamide adenine dinucleotide phosphate oxidase activity. Cancer research\| PubMed ID: 14583492	2003
Enhancement of radiation effects by combined docetaxel and flavopiridol treatment in lung cancer cells. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology\| PubMed ID: 15110456	2004
The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells. Cancer research\| PubMed ID: 16452236	2006
Correlation of HER1/EGFR expression and degree of radiosensitizing effect of the HER1/EGFR-tyrosine kinase inhibitor erlotinib. Indian journal of biochemistry & biophysics\| PubMed ID: 16955736	2005
SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor. Neoplasia (New York, N.Y.)\| PubMed ID: 17534442	2007
Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction. Frontiers of radiation therapy and oncology\| PubMed ID: 17641519	2007
DNA-PKcs-dependent modulation of cellular radiosensitivity by a selective cyclooxygenase-2 inhibitor. International journal of radiation oncology, biology, physics\| PubMed ID: 17707272	2007
Sustained metaphase arrest in response to ionizing radiation in a non-small cell lung cancer cell line. Radiation research\| PubMed ID: 18159951	2008
The death domain-containing kinase RIP1 regulates p27(Kip1) levels through the PI3K-Akt-forkhead pathway. EMBO reports\| PubMed ID: 18566599	2008
Exploring the possibility of unique molecular, biological, and tissue effects with hypofractionated radiotherapy. Seminars in radiation oncology\| PubMed ID: 18725111	2008
The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 19193471	2009
SNS-032 prevents hypoxia-mediated glioblastoma cell invasion by inhibiting hypoxia inducible factor-1alpha expression. International journal of oncology\| PubMed ID: 19287962	2009
The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer research\| PubMed ID: 19339267	2009
RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN. Cancer research\| PubMed ID: 19435890	2009
Radiosensitization of HT-29 cells and xenografts by the nitric oxide donor DETANONOate. Journal of surgical oncology\| PubMed ID: 19507186	2009
Mechanisms of resistance to ionizing radiation in rectal cancer. Expert review of molecular diagnostics\| PubMed ID: 19580431	2009
The 'holi' dermatoses: annual spate of skin diseases following the spring festival in India. Indian journal of dermatology\| PubMed ID: 20161854	2009
Tissue microarray constructs to predict a response to chemoradiation in rectal cancer. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver\| PubMed ID: 20227932	2010
Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation. Cancer research\| PubMed ID: 20332235	2010
Loss of p15/Ink4b accompanies tumorigenesis triggered by complex DNA double-strand breaks. Carcinogenesis\| PubMed ID: 20663777	2010
An orthotopic lung tumor model for image-guided microirradiation in rats. Radiation research\| PubMed ID: 20681800	2010
Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells. International journal of radiation oncology, biology, physics\| PubMed ID: 20970033	2010
Murine orthotopic model for the assessment of chemoradiotherapeutic interventions in rectal cancer. Anti-cancer drugs\| PubMed ID: 21233706	2011
Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction. Frontiers of radiation therapy and oncology\| PubMed ID: 21625164	2011